Vimarsana
Biggest News Aggregation in the World

Page 8 - Histamine News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Histamine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Histamine Today - Breaking & Trending Today

Treatment with antihistamines associated with improved responses to immunotherapy - Vimarsana News

Treatment with antihistamines associated with improved responses to immunotherapy

New research from The University of Texas MD Anderson Cancer Center found that treatment with antihistamines, a commonly used allergy medication, was associated with improved responses to immune checkpoint inhibitors.

AB Mauri set to lead first-ever virtual congress into DAO enzyme deficiency - Vimarsana News

AB Mauri set to lead first-ever virtual congress into DAO enzyme deficiency

The business unit of AB Biotek – which is part of the global yeast and bakery ingredients specialist – is hosting the first International Congress of DAO Deficiency online on 4 November.

AB Maui set to lead first-ever virtual congress into DAO enzyme deficiency - Vimarsana News

AB Maui set to lead first-ever virtual congress into DAO enzyme deficiency

The business unit of AB Biotek – which is part of the global yeast and bakery ingredients specialist – is hosting the first International Congress of DAO Deficiency online on 4 November.

Over-the-counter acid reflux drug appears to improve the odds of survival for COVID-19 patients - Vimarsana News

Over-the-counter acid reflux drug appears to improve the odds of survival for COVID-19 patients

In the early days of the COVID-19 pandemic, doctors in Wuhan noticed something surprising. Many of the elderly patients who survived the virus were poor: not exactly the demographic you would expect to fare well in a health crisis.

Mast cell activation may underlie inflammation in severe COVID-19 - Vimarsana News

Mast cell activation may underlie inflammation in severe COVID-19

A new preprint research paper posted to the medRxiv* server points to mast cells as major culprits in the etiology of severe and critical COVID-19. This could suggest suitable therapeutic and preventive interventions to reduce the morbidity and mortality of this viral illness.